EE280 Cost-Effectiveness of TEVAR With Active Control in Patients With TAA and TBAD: A Japanese Public Healthcare Payer Perspective
Abstract
Authors
Yoko Matsuo Keita Mori Daiki Matsushima Tatsunori Murata Fujio Matsuyama Shota Saito Tomoya Kudo Naoki Tashiro